What is the role of accelerated approval pathways?
Accelerated approval pathways, such as the FDA's Fast Track, Breakthrough Therapy, and Priority Review designations, aim to expedite the review process for drugs that treat serious conditions and fill an unmet medical need. These pathways allow for earlier approval based on surrogate endpoints, with the requirement that post-marketing studies confirm the drug's clinical benefit.
